Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-06 · accession 0001062993-24-016386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-10 | 2024-09-06 | BIO | Last Andrew J. | EVP, COO | S - Sale+OE | $329.94 | -3,000 | 7,559 | -28% | -$989.8K |
| D | 2024-09-10 | 2024-09-06 | BIO | Last Andrew J. | EVP, COO | M - OptEx | $299.24 | +3,000 | 10.6K | +40% | +$897.7K |
| D | 2024-09-10 | 2024-09-06 | BIO | Last Andrew J. | EVP, COO | M - OptEx | $0.00 | -3,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2024-09-06 | S | D | 3,000 | $329.94 | 7,559.45 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2024-09-06 | M | A | 3,000 | $299.24 | 10,559.45 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-09-06 | M | D | 3,000 | $0.00 | 0 | D | $299.24 · — to 2029-04-29 | 3,000 Bio-Rad A Common Stock | (F1) The option, representing a right to purchase a total of 5,000 shares, became exercisable in five equal annual installments beginning on April 29, 2019, which was the first anniversary of the date on which the option was granted. |